- cafead   Feb 06, 2019 at 09:42: AM
via Moderna has announced the dosing of the first subject in a phase 1 clinical trial evaluating the safety and tolerability of escalating doses of mRNA-1944 via intravenous infusion in healthy adults.
article source
article source